Breakthrough COPD Treatment Awaits FDA Approval Promising Major Market Impact

Verona Pharma is poised for a pivotal breakthrough with its drug candidate, ensifentrine, potentially transforming COPD treatment pending an …

Share on Facebook

Tweet

Follow us

Save